Maynard Um
-
-
-
-
-
-
-
Xeris Pharmaceuticals Inc. (XERS) Misses Q3 EPS by 1c ; Offers Guidance
-
-
-
-
-
-
-
Xeris Pharmaceuticals Inc. (XERS) Misses Q1 EPS by 1c, provides guidance
-
-
-
-
-
-
-
Xeris Pharmaceuticals Inc. (XERS) Expects to Exceed Full-Year 2024 Financial Guidance
-
-
-
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

